Active ingredientMoclobemideCat. No. P-M154-001CAS 71320-77-9Family · Pharmaceutical analytical standards
Moclobemide
A benzamide antidepressant that selectively and reversibly inhibits the enzyme monoamine oxidase A (MAO-A), discovered in Switzerland in 1972 and first approved in Sweden in 1989; it is used for depression and social anxiety. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?At first researchers screened it as a possible blood-lipid-lowering drug or antibiotic, but the tests were negative: only later was its action on MAO-A discovered.
Go to the active ingredient →Active ingredientMoclobemideCat. No. P-M154-001CAS 71320-77-9
Isotopically labelledMoclobemide-d4Cat. No. P-M154-002CAS 2929883-33-8
NitrosamineN-Nitroso MoclobemideCat. No. P-M154-003
Impurity4-Chloro-N-(2-hydroxyethyl)benzamideCat. No. P-M154-004CAS 7400-54-6
Impurity4-ChlorobenzamideCat. No. P-M154-005CAS 619-56-7
ImpurityMethyl 4-ChlorobenzoateCat. No. P-M154-006CAS 1126-46-1
ImpurityMoclobemide morpholine C-oxidized derivativeCat. No. P-M154-007
ImpurityMoclobemide N-OxideCat. No. P-M154-008CAS 64544-24-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.